Three children with familial hypomagnesemia from infancy were treated perorally with magnesium for 9 to 12 years. Their somatic and intellectual development have since been normal. Without therapy, the serum magnesium fell from subnormal (about 0.5 mmoles/liter) to very low values (0.2 to 0.3 mmoles/liter) within 1 to 4 wk. We observed a secondary fall in serum calcium and potassium and an increase in sodium and phosphate although serum concentrations of PTH, calcitonin, and 25-OH-vitamin D in the blood remained normal. Balance studies confirmed the presence of a defect in the intestinal absorption of magnesium and excluded a defective renal tubular transport system. The subjects continued to require daily magnesium supplements to avoid serious symptoms. Optimal dosage was found to be in the range 0.5 to 0.75 mmoles/kg*day; doses above this caused diarrhoea and a fall in the serum and urine levels of magnesium. Pathophysiologic mechanisms involved in the electrolyte changes that occurred secondarily to the hypomagnesemia are discussed.
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Speculation
The pathophysiologic basis for the impaired intestinal absorp tion of magnesium in this condition is unknown. In fact, the mechanism by which magnesium is normally transported across membranes is also largely unknown. A facilitated transport mechanism seems to be involved. It appears reasonable to believe that errors in enzymes. or perhaps more likely, in specific magnesiumbinding proteins that are involved in the membrane transport form the molecular basis for familial hypomagnesemia.
Familial hypomagnesemia was first described in 1965 (23).
Subsequently, a total of 18 cases have been reported (2, 4, 6, 7, 10, 13, 15, 19, 23, 24, 26, 28, 30, 31, 32, 34, 37) . In addition, five older siblings of these index cases died with a clinical picture consistent with familial hypomagnesemia, but without a verified diagnosis (Table I) . The usual age of onset was 2 to 4 wk; however, two women first became symptomatic during adulthood. This type of congenital primary hypomagnesemia appears to be due to a specific defect in the intestinal absorption of magnesium (28, 32) .
For 9 to 12 years, we have followed three children with familial hypomagnesemia diagnosed during infancy. In the absence of data from long-term follow-up studies, we have reviewed our subjects as to their growth and development and evaluated their need for extra magnesium supplementation and the degree of homeostatic lability. rGorted previously (28j. He was treated daily with oral magnesium lactate powder until 12 years of age, followed by a magnesium sulphate mixture (0.75 mmoles/kg.day). He has developed normally without convulsions. His serum magnesium has consistently been subnormal: 0.5 to 0.6 mmoles/liter.
T. B., born 8/16/67, was the second child of healthy, nonconsanguineous parents. He was born at term after a normal pregnancy and delivery. Symptoms of hypomagnesemia appeared at the age of 3 wk. The course through infancy has previously been reported (32) . From the fourth wk of life, he received daily supplements of magnesium lactate solution. This was changed at 2 years of age to a magnesium sulphate mixture (0.75 mmoles/kg. day). Despite this medication, his magnesium has been subnormal (0.5 to 0.6 mmoles/liter). On two occasions when the supplements were temporarily discontinued, the serum magnesium fell to 0.3 mmoles/liter. His development has been normal, and neither convulsions nor muscular irritability has occurred. Frequently, he has had loose stools.
In 1966, a n older sibling died at the age of 7 wk after prolonged hypocalcemic convulsions which were resistant to calcium therapy.
A subsequent pregnancy in 1976 ended in a spontaneous abortion at 20 wk of gestation. K. T. born 2/23/69, was the fourth child of nonconsanguineous, healthy parents. Their first child was a boy who died at 8 wk. He had failed to thrive and had muscular weakness but no convulsions. Two younger brothers are healthy.
The patient was born 2 wk preterm with a birth weight of 2830 g and a length of 50 cm. He was breastfed and progressed normally for the first month. He then had several short fits characterized by stiffness and opisthotonus. The symtoms subsided after administration of phenobarbital but reappeared 5 days later. Hypomagnesemia and hypocalcemia were then detected. Treatment was initiated with parenteral and later with oral magnesium. Balance studies at 3 months of age, performed as previously described (32) . showed a net intestinal absorption of magnesium of 18%, but a normal absorption of calcium (48% of intake) and phosphate (59% of intake). Seventy-eight percent of a single oral load of "'SrClr (2 pCi) was absorbed, suggesting a normal absorption of strontium. Magnesium supplementation was initially given as lactate powder and later as a sulphate mixture (0.50 mmoles/kg.day). Apart from occasional loose stools, he has been asymptomatic but with subnormal serum magnesium levels (0.5 to 0.6 mmoles/liter). His development has been normal. OUTPATIENT STUDIES (38) 
SUBJECTS A N D M E T H O D S
During the first part of the study, the subjects were treated with standardized doses of oral magnesium supplements (0.75 mmoles/ SUBJECTS kg-day) for 4 wk. Then the magnesium therapy was discontinued, and the subjects were reviewed at weekly intervals. If clinical M. M., born 6/11/66, was the first child of healthy, nonconsan-symptoms or signs appeared or the serum magnesium dropped guineous parents. Symptoms of hypomagnesemia appeared at the below 0.3 mmole/liter, the therapy was resumed in a stepwise F A M I L I A L HYPOMAGNES~E$IA 1135 fashion. Initially, 0.25 mmole/kg.day was given. When a steady liter) a n d o casionally intramuscularly dissolved in water ( I mole/ state was reached. usually after 3 to 4 wk, another 0.25 mmole/kgliter). day was added. The oral supplementation was thus increased in increments of 0.25 mmole/kg.day until diarrhoea occurred and/ I LABORATORY METHODS or the serum magnesium began to fall.
VariouS ematologic parameters. electrolytes, and small-molec-
INPATIENT STUDIES (38)
d ular components, proteins, amino acids, and enzymes were measured by cdnventiona~ methods. Magnesium, calcium. and zinc The subsequent investigation was performed in the hospital. were assay by atomic absorption spectrophotometry, Ionized Apart from a clinical and extensive biochemical examination, this calcium determined in serum (anaerobically handled) using comprised a balance study lasting 7 days during which time the an electrode (F 21 12 Ca; Calcium Selectrode, Radidietary intake as well as the fecal and urinary excretion of magImmunoreactive parathyroid hormone was nesium. calcium, sodium. potassium, phosphate, and nitrogen determined (39) by a C-terminal specific radioimmunoassay as were quantitated. Carmine red served as marker of intestinal recently des 1; ribed by Gautvik et al. (12) . Antisera from rooster passage. A peroral load of "%strontium chloride (The Radiochem-which was raised against bovine parathyroid hormone (PTH) and ical Center, Ammersham, England) was given to examine the which croksqreacted with human hormone was used as antibody, intestinal absorption of this metal. Magnesium supplementation and 12"I-labeled purified bovine PTH was used as tracer. The was discontinued 2 wk (M. M. and K. T.) and 5 days (T. B.) wk before the balance studies. Magnesium was administered therapeutically as sulphate, usually perorally as a mixture (0.5 mole/ Fig. 3 ; T. B., Fig. 4 ; K. T. Fig. 5 
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RESULTS
DEVELOPMENTAL AND CLINICAL STATUS
The subjects' respective height and weight percentiles on admission to the hospital were: M. M., both 90th; T. B.. both just below 50th; K. T., both 30th. Although formal psychological testings were not carried out, the subjects' intellectual status appeared normal, and they performed normally at school. No abnormalities were detected upon clinical examinations [apart from tetanic symptoms and signs which occurred after a long period without magnesium supplementation (see below)]. Their bone ages were normal.
BIOCHEMICAL STATUS
During periods of magnesium curtailment, low serum concentrations of magnesium developed (see below). Other electrolyte changes also occurred ( Fig. 1) which were probably secondary to the hypomagnesemia. Apart from these changes, a remarkably normal biochemical status was found. Thus, various serum components such as proteins (including agarose gel electrophoresis), enzymes (aspartate and alanine aminotransferase, lactate dehydrogenase, y-glutamyltransferase, alkaline, and acid phosphatases), urea, creatinine, triglycerides, cholesterol, HDL-cholesterol, Weeks FAMILIAL HYP( amino acids in serum and urine, as well as ordinary hematologic parameters were all within the reference ranges. Serum zinc levels (16 to 19 mmoles/liter) were in the higher normal range. Serum hormones, immunoreactive PTH (upper reference limit, 0.6 pg/ liter), immunoreactive calcitonin (upper reference limit, 0.5 pg/ liter) and 25-OH-vitamin D (reference range, 20 to 100 nmoles/ liter) including the vitamin D binding transport protein [group specific component (Gc) globulin (14)], fell within reference ranges both while on and off magnesium therapy (Fig. 2) .
INTESTINAL ABSORPTION
The results of the balance studies are summarized in Table 2 . An average of 87% of the magnesium intake was recovered in the feces, with a variation from 78 to 101%. A low level of calcium absorption was also found, ranging from 3 1 to minus 4% and the absorption of strontium averaged 17%, whereas the absorption of sodium, potassium, phosphate, and nitrogen was in the high normal range. The glucose tolerance, the xylose tolerance, the vitamin A absorption test, and the Schilling test were normal in all subjects. The fecal fat excretion was 2.1, 2.0, and 1.6 g/day for M. M., T. B. and K. T., respectively.
RESPONSE TO CURTAILMENT OF MAGNESIUM SUPPLEMENTATION
During the outpatient period, all three subjects showed a significant decrease in serum Mg in the first wk without magnesium supplementation (Figs. 3 to 5) . T. B.'s magnesium level dropped below 0.3 mmole/liter within 6 days (Fig. 4) , and K. T. reached this level within 3 wk (Fig. 5) . M. M. reached a steady level of 0.35 mmole/liter in 4 wk (Fig. 3) . During the first 2 wk, the urinary magnesium concentration in all subjects fell below 0.1 mmole/liter~ A similar decrease occurred in the concentration of calcium in serum and urine (Figs. 3 to 5 ), but the calcium changes in serum occurred later and were less marked than those of magnesium. In fact, the serum Ca did not fall below the lower reference limit in any of the subjects during the whole period.
Similar serum (Fig. 6 ) and urinary changes (not shown) were found during the inpatient period. On admission (off therapy). ionized calcium was between 1.15 and 1.19 mmoles/liter, whereas at discharge (on therapy), it was between 1.23 and 1.25 mmoles/ liter (reference range. 1.10 to 1.30 mmoles/liter). The concentration of erythrocyte magnesium (reference range, 1.70 to 3.00 mmoles/liter) was between 1.43 and 1.45 mmoles/liter immediately before therapy and between 1.53 and 1.64 mmoles/liter at discharge. On the fourth day after admission, K. T. demonstrated slight tetanic cramps. The other two subjects had positive Chvostec signs. Oral magnesium supplementation was therefore resumed (0.5 mmole/kg,day) with K. T. receiving IM magnesium sulphate (3 mmoles) immediately. The signs of tetany disappeared within minutes after the injection.
DISCUSSION
The results of this study show that children with familial hypomagnesemia grow and develop normally when they are given daily oral magnesium supplementation. It was also established that the subjects have a continual need for additional magnesium. Without therapy, the onset of symptoms of hypomagnesemia might be delayed for several wk, provided that there were already replete body stores of the mineral or that the dietary intake of magnesium was high. Optimal oral supplementation of magnesium sulphate was found to be from 0.5 to 0.75 mmole/kg.day. Higher doses caused diarrhoea, and no further increase in serum Mg occurred. The subsequent fall in serum and urinary magnesium. which was seen on high doses, suggested that the degree of magnesium absorption was not only positively correlated to the intraluminal magnesium concentration but also inversely correlated to the intestinal transit time.
Previous studies on infants with familial hypomagnesemia have suggested the existence of a defect in the intestinal absorption of magnesiurh 23, 26, 28, 32) . This conclusion is supported by the results rep0 1 ed here. Healthy adults on an ordinary diet (about 10 mmoles/ ay) excrete in feces 50 to 60% of the magnesium injected (1). d Studies with experimentally induced magnesium th in animals and man (9, 27) have shown an adaptive deficiency ihc ? ease in the magnesium absorption as a deficiency develops. The absorption may in fact approximate 100% (5) there fore,^ n absorption of less than 25% (average. 13%) as observed in our three magnesium-deficient children, seems to confirm the resence of a n ~ntestinal defect.
A low a b 1 orption was also found for calcium (less than 35%. average 18%). However, we have no reason to believe that there was also an bsorption defect for this cation. Thus, a spontaneous return of de I m Ca to normal levels occurred when magnesium alone was given. Moreover, the calcium absorption for K. T. in the neonatlal period was found to average about 50%. which had also previou 1 ly been shown for T. B. (32%).
Previously we had found that K. T. absorbed n%trontium to a high degree in the neonatal period (see "Subjects"). On this I occasion, the three subjects absorbed on an average of 17% of a single oral lo d. This is on the same order of magnitude found for calcium. he data, therefore, d o not seem to support the findings by Nordio et al. (19) of an absorption defect also for strontium. orm mall), there is a positive correlation between the urinary excretion of 1 alcium and magnesium (expressed. e.g., in pmoles/ liter glomeru ar filtrate) and the level of these minerals in plasma (i.e., the ultr I filtrable fraction) (18). This relationship is particuconcentratio , as found in our subjects, does no< exclude the presence of 9 defect in the tubular reabsorption mechanism because the plasma concentration was reduced in this period. too. However, whkn matching the excretion rate with the plasma levels, the values fot all three subjects fell below and to the right of an 1138 STRBMME ET AL. experimentally determined correlation curve both for magnesium and for calcium (Figs. 7 and 8) . This indicates that the reabsorption of these ions was. in fact. stimulated. The findings seem to exclude the presence of a renal defect of functional importance. Our patients therefore must be different from the one recently described by Nutbeam er al. (20) . Their patient was considered to have a combined renal and intestinal magnesium transport defect and showed, in contrast to ours, moderate hypercalcemia. Fig. 7 . The relation between serum concentration and urinary excretion of magnesium in the three patients during a period without magnesium treatment [after 3 days in hospital. Fig. 6 (left points)] and with treatment [after 6 and 7 days in hospital, Fig. 6 (right points)] . The broken curve represents a reference curve based on results from 28 normal subjects and 13 subjects after magnesium depletion (remodilied from Ref. 19. Fig. 5.19 ).
S -Calcium ( mmol/l ) Fig. 8 . The relation between serum concentration and urinary excretion of calcium in the three patients under conditions as given in Figure 7 .
Reference ranges are indicated by the broken curves (redrawn from Ref. 19 . Fig. 13 .2).
Our three subjects provided an unique possibility for examining the secondary ei'fects'oc a primary magnesium deficiency. Hypomagnesemia-induced hypocalcemia. resistant to calcium therapy, is the most prominent and regular secondary electrolyte change. All of our subjects showed a consistent but moderate fall in serum calcium as hypomagnesemia developed. Several theories have been proposed to explain the pathophysiologic mechanisms underlying this type of hypocalcemia (8. 29). These include: a reduced peripheral response to PTH (17, 19, 21, 37) : a reduced synthesis/release of PTH from the parathyroid gland (2. 3. 33) : increased serum calcitonin (33) ; decreased active vitamin D metabolites (e.g., 1,25-diOH-Vit-D) (16, 21) ; and an abnormal distribution of calcium among the various body compartments (25, 32) .
Most frequently. PTH has been considered to be involved. Several authors have found reduced or blocked peripheral response to PTH (19. 37) . Others have reported evidence suggesting a reduced synthesis/release of PTH. Thus, Anast et al. (2) and Suh er al. (33) described a low serum PTH in the hypomagnesemic/hypocalcemic period in familial hypomagnesemia and a spontaneous increase in serum PTH on magnesium therapy (2). In contrast. the serum PTH level in our three subjects was within the normal range during the hypomagnesemic and hypocalcemic periods. This suggests an inappropriate response of the parathyroid gland (Fig. 2) . Moreover, there was no significant change in serum levels of PTH on magnesium therapy (Fig. 2) . In this respect, the literature is extremely controversial. High, normal, and low values have been described in patients with profound hypomagnesemia (29). Both methodologic and pathophysiologic factors may have caused these descrepant observations. The peripheral response to parenteral PTH was not tested. but indirect evidence for an intact response was found in an efficient renal reabsorption of calcium (Fig. 8) . On the other hand. a reduced response may be interpreted from finding a high normal tubular absorption of phosphate (TRP) value during the hypomagnesemic period (M. M., 92%; T. B., 93%; K.T., 89%). and a higher urinary excretion during magnesium therapy (T. R. P.: M. M., 86%: T. B., 88%: K. T., 87%). T R P was always within our reference range (83 to 95%). Consequently, a significant block in renal response to PTH seems unlikely. Normal levels were also found for calcitonin and 25-OH-vitamin D [including the vitamin D binding Gcprotein in serum (14) ]. The present data, therefore, failed to provide evidence that any of the hormones PTH, calcitonin, or vitamin D metabolites are essential in the development of the secondary hypocalcemia.
Hypomagnesemia-induced hypokalemia, resistant to potassium therapy, has also been shown in animal experiments and recently observed in man (27, 36) . It seems to be less frequent and less marked than the corresponding hypocalcemia. but occurred in our subjects on both occasions when magnesium supplementation was discontinued (Fig. I) . There was simultaneous fall in serum potassium and a slight increase in serum sodium (Fig. l) . Earlier studies have failed to show significant alterations in serum sodium (27) . Similarly, an increase in serum phosphate occurred in our patients. On Mg therapy, the serum phosphate fell as the urinary excretion increased (results not shown) and the T R P decreased. An increasing serum phosphate and a spontaneous fall after magnesium administration have also been noticed in experimental magnesium deficiency, but the reported findings have been inconsistent (27) . No difference was found in the serum osmolality either with or without therapy.
Familial hypomagnesemia appears to be an autosomal recessive disorder (6, 28, 3 I ), but it is most frequently diagnosed in boys. The biochemical substrate for the malabsorption has not as yet been found, but a causal defect or absence of a specific protein (enzyme) is likely. In fact, the detailed mechanism by which magnesium is transported across cell membranes is still unclear (1 ).
